80+
Countries
500+
APIs Available
30yr
Experience
WHO
GMP Certified
Bio Pharma Primo Impex
Bio Pharma Primo Impex · Est. 1995
LIVE · WHO-GMP
Bio Pharma Primo Impex — Global Leader

Fostering
Life
with Bio Health.

World-class pharmaceutical solutions across 80+ nations — API sourcing, contract manufacturing, finished form development & global supply chain excellence.

✅ WHO-GMP Certified
🌍 80+ Markets Active
⚗️ 500+ APIs Available
Live Operations
Active
80+
Countries
30yr
Experience
WHO-GMP FDA Reg. ICH ISPE
Global Reach80%
Scroll
01
Inquiry
02
Assessment
03
Proposal
04
Contract
05
Delivery
02 — Our Core Services

What We Deliver

02
💊
Finished Form Dev.

Tablets, injectables, liquids, capsules — developed and validated for international regulatory standards globally.

Discover More →
04
🌐
Global Supply Chain

End-to-end logistics from sourcing to last-mile delivery across 80+ markets with cold-chain and customs mastery.

Discover More →
06
🧬
API Intermediates

Premium pharmaceutical intermediates with full DMF dossiers — cGMP certified, CEP/KDMF/ANVISA filed, globally sourced.

Explore Intermediates →
WHO-GMPCertified Manufacturer
80+Countries Served
30 YearsIndustry Experience
FDARegistered Facility
500+API Products
ISPEState-of-the-Art Infrastructure
ICHGuidelines Compliant
Est. 1995Trusted Globally
WHO-GMPCertified Manufacturer
80+Countries Served
30 YearsIndustry Experience
FDARegistered Facility
500+API Products
ISPEState-of-the-Art Infrastructure
ICHGuidelines Compliant
Est. 1995Trusted Globally
03 — By the Numbers

Our Impact

Live Reach
51+
Countries Served
0yr
Industry Experience
Est. 1995 · Trusted Globally
STATE OF
THE ART
Facility
ISPE Infra
World Health Org.
WHO
GMP
Compliant Manufacturing
✅ Certified
04 — Global Presence

Delivering life-saving
medicine across
80+ markets.

🇺🇸
🇩🇪
🇯🇵
🇧🇷
🇿🇦
🇸🇬
🇦🇪
80+ partner nations
Global Pharma Partner Map
Europe · 54%
United Kingdom
Germany
Poland
Italy
North America · 25%
United States
Canada
Mexico
South America · 4%
Brazil
Argentina
Asia & Oceania · 14%
Global Network
China
Japan
South Korea
Singapore
Australia
UAE / MENA
Saudi Arabia
Turkey
Africa · 3%
South Africa
Nigeria
Kenya
80+ Countries Active Partners
WHO-GMP Certified Supply
30 Years Global Experience
500+ Pharmaceutical Products
Distribution by region
Europe
54%
North America
25%
Asia & Oceania
14%
South America
4%
Africa & MENA
3%
05 — In Depth

Key Services

Drag to explore
02
💊
Finished Form Dev.

Tablets, capsules, injectables, liquids — developed and validated to meet international regulatory standards across global markets.

Learn More →
04
🌐
Global Supply Chain

End-to-end supply chain management — from sourcing to last-mile delivery across 80+ markets with cold-chain and customs expertise.

Learn More →
05
🔬
R&D Partnership

Collaborative research and development initiatives supporting novel formulations, bioequivalence studies, and regulatory dossier preparation.

Learn More →
06
📋
Regulatory Affairs

Expert guidance through ICH, WHO, FDA and regional regulatory submissions — ensuring market access with speed and precision.

Learn More →
06 — Compliance & Trust

Built on Trust

🏅
WHO-GMP

Internationally recognized quality standard for pharmaceutical manufacturing globally.

🔒
FDA Registered

Full US FDA registration and compliance for export-grade pharmaceuticals worldwide.

🌿
ESG Committed

Sustainable and environmentally responsible pharmaceutical manufacturing practices.

📋
ICH Guidelines

Full adherence to International Council for Harmonisation standards across all operations.

07 — What Partners Say

Hear from our Partners

"Exceptional reliability and regulatory expertise. Bio Pharma Primo Impex has been our strategic API partner for 8 years with zero supply disruptions."

🇩🇪
Stefan M.
VP Procurement · Germany

"Their WHO-GMP certification and deep ICH knowledge made market entry into Japan seamless. Highly recommend for complex regulatory landscapes."

🇯🇵
Yuki T.
Director · Tokyo

"From formulation to cold-chain delivery across 12 African markets — they delivered on time, every time. A true global supply partner."

🇿🇦
Amara N.
CEO · South Africa

Ready to partner with a
global manufacturer?

Talk to our team about supply chain, formulation, or regulatory needs.

WHO-GMP Certified

Certified by

WHO-GMP

🌐
✉️
📞
Global Reach
Our Global Footprint

Reaching Every
Corner of the Globe

Bio Pharma Primo Impex delivers WHO-GMP certified pharmaceutical products across 80+ markets — from West Africa to Southeast Asia, with full cold-chain compliance and regulatory integrity.

80+
Countries Served
200+
Products Distributed
20+
Years of Experience
100%
WHO-GMP Compliant

Where We Operate

🌍 Africa
🇳🇬🇬🇭🇸🇳
West Africa
Nigeria, Ghana, Ivory Coast, Senegal, Sierra Leone, Liberia, Guinea, Guinea-Bissau, Gambia, Togo, Benin, Burkina Faso, Mali, Niger, Cape Verde, Mauritania
Primary Market
🇰🇪🇹🇿🇺🇬
East Africa
Kenya, Tanzania, Uganda, Ethiopia, Rwanda, Burundi, Mozambique, Zambia, Malawi, Zimbabwe, Madagascar, Comoros, Mauritius, Seychelles, Reunion
Active
🇿🇦🇧🇼🇳🇦
Southern Africa
South Africa, Botswana, Namibia, Lesotho, Eswatini, Angola, Mozambique, Zimbabwe, Zambia
Active
🇪🇬🇲🇦🇹🇳
North Africa
Egypt, Morocco, Tunisia, Algeria, Libya, Sudan, Western Sahara
Active
🇨🇩🇨🇲🇨🇬
Central Africa
Democratic Republic of Congo, Cameroon, Chad, Central African Republic, Congo-Brazzaville, Gabon, Equatorial Guinea, São Tomé & Príncipe
Active
🇸🇴🇪🇹🇩🇯
Horn of Africa
Somalia, Djibouti, Eritrea, South Sudan, Sudan, Ethiopia
Growing
🌏 Asia
🇮🇳🇧🇩🇱🇰
South Asia
India, Bangladesh, Sri Lanka, Pakistan, Nepal, Bhutan, Maldives
Active
🇸🇬🇲🇾🇹🇭
Southeast Asia
Singapore, Malaysia, Thailand, Vietnam, Philippines, Indonesia, Myanmar, Cambodia, Laos, Brunei, East Timor
Active
🇨🇳🇯🇵🇰🇷
East Asia
China, Japan, South Korea, Taiwan, Hong Kong, Macau, Mongolia
Growing
🇰🇿🇺🇿🇹🇲
Central Asia
Kazakhstan, Uzbekistan, Turkmenistan, Tajikistan, Kyrgyzstan, Afghanistan
Growing
🕌 Middle East
🇦🇪🇸🇦🇶🇦
Gulf States (GCC)
UAE, Saudi Arabia, Qatar, Kuwait, Oman, Bahrain
Active
🇯🇴🇱🇧🇮🇶
Levant & Iraq
Jordan, Lebanon, Iraq, Syria, Palestine, Israel
Active
🇮🇷🇾🇪
Persia & Yemen
Iran, Yemen
Growing
🌏 Oceania
🇦🇺🇳🇿🇵🇬
Oceania & Pacific
Australia, New Zealand, Papua New Guinea, Fiji, Solomon Islands, Vanuatu, Samoa, Tonga, Kiribati, Tuvalu, Palau
Growing
Regulatory Compliance
WHO-GMP Certified
Regulatory Compliance

Meeting the
World's Highest
Standards

Regulatory compliance means adhering to the legal, ethical, and quality standards set by national and international authorities throughout the drug lifecycle — from research and clinical trials to manufacturing, distribution, and post-market monitoring.

Global Regulatory Coverage
80+
Compliant Markets
100%
WHO-GMP Certified
20+
Years Compliance
500+
Approved Products
FDA EMA WHO-GMP ICH TGA MHRA
Why It Matters

The Importance of Compliance

These regulations have been shaped over many years through scientific study, public health priorities, and experiences with past safety issues. Adhering to them helps ensure that pharmaceutical products remain safe, effective, and meet quality standards no matter where they are produced or distributed.

🛡️
Protects Patient Safety
Regulations help prevent issues like contamination, incorrect dosages, or adverse reactions by requiring strict quality controls at every stage of the drug lifecycle.
💊
Keeps Products Effective
Medications are tested thoroughly to confirm that they work as intended and continue to do so throughout their entire shelf life.
⚖️
Prevents Legal Consequences
Failure to follow rules can result in recalls, bans, fines, or even legal action against the company — protecting the organisation from costly penalties.
🏆
Builds Public Trust
Meeting compliance boosts a company's reputation with regulators, doctors, and the public — a critical asset in the pharmaceutical industry.
🌍
Enables Global Market Access
Compliance is needed to get approval to sell drugs worldwide. Without it, medicines cannot make it to the patients who need them most.
🔬
Supports Innovation
By keeping systems transparent and dependable, compliance frameworks allow companies to innovate responsibly, accelerating the development of new therapies.
Key Authorities

Regulatory Bodies & Standards

Pharmaceutical compliance is overseen by both national and international regulatory authorities. Every regulatory agency sets rules to make sure medications are safe, effective, and high in quality.

🇺🇸
U.S. Food and Drug Administration
FDA
Oversees the approval and monitoring of pharmaceutical products in the United States, with regulations like 21 CFR Part 210/211 (manufacturing) and 21 CFR Part 11 (electronic records). Critical role in clinical trial approvals, labeling, marketing compliance, and post-market surveillance.
🇪🇺
European Medicines Agency
EMA
Evaluates medicinal products for use across EU member states. Promotes harmonisation of safety and efficacy standards through the centralised authorisation procedure, ensuring consistency across the region.
🇨🇦
Health Canada
HPFB
Through its Health Products and Food Branch, Health Canada regulates pharmaceuticals, ensuring they meet Canadian standards for safety, efficacy, and quality throughout their lifecycle.
🌐
International Council for Harmonisation
ICH
Brings together regulators and industry experts to create shared global guidelines. ICH standards reduce duplication of efforts for multinational companies and accelerate drug approvals across multiple markets simultaneously.
🇦🇺
Therapeutic Goods Administration
TGA — Australia
Regulates therapeutic goods including prescription medicines, vaccines, and medical devices in Australia. Adapts global standards to Australian requirements and enforces compliance across all market participants.
🇬🇧
Medicines & Healthcare Products Regulatory Agency
MHRA — UK
The UK's post-Brexit regulatory body for medicines and medical devices. Enforces compliance with UK-specific standards while maintaining alignment with international guidelines and WHO-GMP requirements.
Framework

Components of Compliance

Pharmaceutical compliance spans a drug's entire lifecycle. Each component is designed to uphold legal requirements while ensuring patient well-being and product reliability.

01
Regulatory Submissions & Approvals

Before a drug reaches the market, it undergoes a thorough review. Regulatory bodies check for safety, effectiveness, and quality before giving the green light.

  • IND Applications: Filed before clinical trials, sharing early research and plans for human testing.
  • NDA & ANDA: Submitted for approval of new drugs or generics, providing evidence of clinical trial results, manufacturing processes, and proposed labeling.
  • Marketing Authorisation Applications (MAA): For obtaining marketing approval in specific regions such as the EU.
02
Good Manufacturing Practices (GMP)

GMP refers to a set of regulations and guidelines governing the production of pharmaceutical products, ensuring they are produced consistently and controlled to the highest quality standards.

  • Raw Material Quality: Confirming that all materials used in production meet defined quality standards.
  • Facility Conditions: Production areas must meet cleanliness and safety benchmarks at all times.
  • Production Processes: Every step must be documented and verified to ensure consistent, reproducible outcomes.
03
Good Clinical Practices (GCP)

GCP ensures clinical trials are conducted ethically and that the data collected is trustworthy and reproducible across all trial sites.

  • Informed Consent: Participants must clearly understand the trial and voluntarily agree to join.
  • Trial Design: Studies must follow detailed, well-documented and pre-registered protocols.
  • Data Management: All trial data must be accurate, complete, and fully traceable to source.
04
Post-Market Surveillance & Pharmacovigilance

Compliance doesn't stop once a drug is approved. Companies need systems in place to monitor real-world performance and catch any issues early.

  • Adverse Event Reporting: Any negative reactions must be reported promptly to regulatory authorities.
  • Risk Management: Plans must be in place to handle all known and emerging risks.
  • Product Recalls: Companies must be ready to act fast if safety concerns arise post-approval.
05
Labeling & Advertising Compliance

Regulations ensure marketing claims are fair and truthful, applying to materials shared with both healthcare professionals and consumers alike.

  • Product Labeling: Must clearly outline usage, side effects, storage instructions, ingredients, and expiry dates.
  • Advertising Standards: All marketing must follow FDA OPDP (US) and EMA guidelines (EU), ensuring every claim is backed by scientific evidence.
06
Data Integrity & Security

As more processes go digital, maintaining trustworthy records becomes essential. Regulations like 21 CFR Part 11 (US) and Annex 11 (EU) guide how digital systems are managed.

  • Change Tracking: Every modification must be logged and attributed to a specific user and timestamp.
  • Security Measures: Systems must guard sensitive data from unauthorized access and cyber threats.
  • System Validation: All electronic tools must be tested and proven reliable before use in regulated environments.
Key Challenges

Staying Compliant

Staying compliant isn't always simple. It takes ongoing effort and resources to keep up with shifting expectations and evolving market demands across every region we serve.

01
Complex & Changing Requirements
As science advances, so do regulations. New therapies like biologics or personalized medicine bring new rules. Staying informed and adaptable is crucial for every market.
02
Global Regulatory Variations
For companies operating across borders, handling different rules in each market is time-consuming and complex. Significant differences remain even as bodies like ICH work toward harmonisation.
03
Data Integrity & Security Risks
With cyber threats growing more advanced, protecting digital systems handling clinical trials, manufacturing records, and regulatory reports is critical. 21 CFR Part 11 requires data to be secure and unalterable.
04
Clinical Trial Compliance
Clinical trials are vital but come with strict oversight. Regulators expect companies to follow GCP to ensure ethical trials, trustworthy data, and consistent patient protection across all sites.
05
Resource & Expertise Limitations
Maintaining compliance requires specialized expertise. Keeping pace with regulations across major markets like the US and EU demands dedicated teams and significant ongoing investment.
06
Accurate Labeling
Misleading or incomplete product labels can lead to major penalties. Labels must clearly state ingredients, dosage, usage instructions, side effects, and expiration dates in every target language.
Our Approach

Strategies for Effective Management

Compliance isn't just a checkbox — it's a mindset. The right systems and culture make all the difference in delivering safe, approved products to patients worldwide.

📋
Dedicated Compliance Framework
Clear guidelines, defined roles, and internal checks ensure everyone stays aligned with FDA, EMA, and ICH standards. Regular audits catch and correct gaps before they become problems — keeping every product market-ready.
💻
Technology & Compliance Management Systems
We use modern platforms to automate record-keeping, track regulatory changes across all markets, and maintain 21 CFR Part 11-compliant data trails — reducing manual errors and keeping the team audit-ready at all times.
⚠️
Risk-Based Approach
Regular risk reviews direct attention to areas that pose the greatest danger to patient safety or legal compliance. This ensures our time and resources make the biggest possible impact where it matters most.
🧠
Culture of Compliance
Ongoing staff training, leadership backing, and continuous improvement keep compliance embedded in everything we do. When people genuinely own compliance, the risk of mistakes and oversights falls dramatically.
🤝
Strong Regulatory Relationships
Open communication, early engagement, and regular consultation with regulatory bodies help us understand expectations clearly — avoiding surprises and building the mutual trust that accelerates approvals.
📡
Monitor & Respond to Change
We subscribe to regulatory updates, attend global events, and engage with compliance experts. When rules change, we update labels, manufacturing steps, or documentation quickly — avoiding costly delays or penalties.
International Standards

Global Harmonisation

Pharmaceutical companies often operate globally, facing different rules in each country. International groups like the ICH bring together regulators and industry experts to create shared guidelines — making multi-market compliance more achievable for everyone.

📉
Reduced Compliance Burden Harmonized regulations reduce duplication of efforts for multinational companies operating across many jurisdictions.
🚀
Faster Market Access Drugs can be approved more quickly across multiple regions when submitted under harmonised guidelines.
🛡️
Improved Global Safety Consistent safety standards are applied worldwide, protecting patients regardless of geography.
💰
Reduced Costs Use the same documentation packages across multiple markets, cutting preparation costs significantly.